The State Council joint prevention and control mechanism: New crown vaccination will not cause leukemia and diabetes

On July 23, at the press conference of the joint control mechanism of the State Council, Wang Fusheng, director of the Infectious Disease Medical Department of the Fifth Medical Center of the General Hospital of the PLA, said that vaccinating the new crown vaccine will not cause leukemia and diabete Affecting the genetic development of the human body, leading to tumor metastasis and diffusion, and reinforcement of antibody dependence, these are irresponsible words on the Internet.

Recently, the local epidemic is more distributed, and the situation of frequent prevention and control situations is severe and complicated.

The National Health Commission spokesman Mi Feng said at the press conference of the State Council's joint prevention and control mechanism on the 23rd that according to the World Health Organization report, the newly -added diagnosis cases in the Western Pacific region of China increased by 37%last week, which is the world's most growth. Fast area. Omikon BA.5 Asian branches have spread to more than 100 countries and regions around the world, leading to an increase in the number of infections, hospitalization, and severe illnesses, and China's foreign defense input pressure has continued to increase.

Recently, the local epidemic has shown a multi -point and frequent trend, and the outflows of the epidemic in some areas have not been completely blocked, and the situation of preventing and control is severe and complicated.

Mi Feng said that it is necessary to adhere to the overall strategy of "external prevention input, internal prevention and rebound" and the general policy of "dynamic clearing zero". In areas where the epidemic occurs, the agglomeration epidemic should be disposed of. To curb the spread of the local epidemic, border areas and immigration cities must strictly implement various measures and input measures, strictly closed loop management, and resolutely avoid the prevention of breaking the ring and spilling of the epidemic; Maintain an emergency response command system efficient operation.

The national cumulative report of the new crown virus vaccine 3416.727 million doses. At least 1 dose of new crown virus vaccination rates over 60 years of age are 89.6%

Zeng Yixin, deputy director of the National Health and Health Commission, stated at the press conference of the State Council's joint prevention and control mechanism on the 23rd that as of July 22, 2022, 31 provinces (autonomous regions, municipalities) and Xinjiang Production and Construction Corps reported a total of 341,6727 million new crown virus vaccines. In order, the total number of vaccinations of vaccination reached 1298.636 million, and the first in vaccination rate of the first dose was 92.1%; of which 126.4901 million were completed, and the entire in vaccination rate was 89.7%. It is 71.7%.

Zeng Yixin introduced that at present, at least 1 dose of new crown virus vaccination rates over the age of 60 or more in my country are 89.6%, the basic immunization rate is 84.7%, and the immune vaccination rate is 67.3%.

Zeng Yixin said that at present, the coverage of vaccination coverage of the elderly over 60 years of age and over 60 years of age has been greatly improved, but there is still room for improvement: one is the vaccination coverage of elderly people over 80 years old, and the other is the elderly Strengthen the vaccination rate.

Specifically, at least 1 dose of vaccination rate of at least 1 dose of 60-69 years old is 91.8%, and the basic immunization rate is 89.1%; at least 1 dose of vaccination rate of at least 1 dose of 70-79 years old is 92.7%, and the basic immunization rate is 87.1. %; At least 1 dose of vaccination rates over 80 years of age are 73.5%, and the basic immunization rate is 61.0%. The enhanced needle vaccination of the elderly is: to strengthen the immune vaccination rate of 60-69 years old; the increasing immune vaccination rate of 70-79 years old is 69.9%; people over 80 years old strengthen the immune vaccination rate of 38.4%.

Zeng Yixin introduced that whether it is domestic or overseas data, because the elderly suffer from basic diseases, once the new crown virus is infected, whether it is early strains or the popular Omikon mutant strains now high. The elderly are also different from young people, and the immune function is relatively weak. It requires inoculation to enhance the needle to obtain the best protection effect.

The R & D work of Omicor Rong's Vaccine is steadily promoting steadily and rapidly

Feng Zijian, Executive Vice President of the Chinese Association of Prevention Medicine, said at a press conference on the joint prevention and control mechanism of the State Council that the mutant strain of Omikon is relatively large, and the degree of mutation is relatively large, and the immune escape ability is relatively strong. It has a certain effect on the neutralized antibodies that have been induced by the existing vaccines and past infections, but immune protection not only depends on neutral antibodies, but also related to cellular immune and immune memory. Therefore, the results of many studies show that the effects of existing vaccines at home and abroad still maintain a high level. my country's vaccine still has a good protective effect on the severe disease and death caused by the mutant strains of Omikon, and strengthening immunity can further reduce the risk of hospitalization, severe and death.

Feng Zijian said that regarding the research and development of Omikon's mutation plant vaccine, the joint defense and control mechanism technology group vaccine research and development special classes were listed on December 26, 2021 The next day, it was organized to organize experts and set up research and development. At present, a number of technical routes have developed the development of unit prices and multi -price Omikon variants. The fast -moving unit price of Omikon variants has been approved by clinical trials and is conducting clinical trials in Zhejiang, Hunan, Hong Kong and other places. The rapid progress of tetramid restructuring protein vaccine has been approved by the UAE's phase III clinical trial, and related research has been launched. Many other unit -prices, multi -price containing Omir Rongjuki, restructuring protein vaccine, adenovirus vector vaccine, and MRNA vaccine are also conducting pre -clinical research. material. In addition, the special class also deployed the research on the broad -spectrum new crown virus vaccine, and the rapid progress of vaccine has been approved by clinical trials, and related research has been launched. Feng Zijian introduced that the research and development of Omikon's Vaccination of Omikon mutation is steadily promoting. As long as there is a need, in accordance with relevant regulations, the emergency use procedures can be quickly launched to provide vaccination. As for whether it is necessary to vaccinate and when to take vaccination specifically for Omikon -containing variants, this problem is not only in my country, but also internationally studying, mainly to study virus mutation and immune escape.

- END -